PBAC chair on Covid antivirals review

By Megan Brodie 2 years ago | In Products, Regulatory
  • 2 years ago
PBAC Chair Professor Andrew Wilson.

27 June 2022 The PBAC will consider widening access to PBS-listed Covid antivirals Paxlovid and…

This is subscriber-only content. Please login to continue reading.